Skip to main content
Karolinska Development logo

Karolinska Development — Investor Relations & Filings

Ticker · KDEV ISIN · SE0002190926 LEI · 54930011ZA52NKO5W681 ST Financial and insurance activities
Filings indexed 761 across all filing types
Latest filing 2019-09-12 Capital/Financing Update
Country SE Sweden
Listing ST KDEV

About Karolinska Development

https://www.karolinskadevelopment.com/en

Karolinska Development is an investment company specializing in the life sciences sector. It identifies, finances, and supports the creation and growth of companies developing innovative medical technologies and pharmaceuticals. The firm manages a diversified portfolio of biotechnology and medtech ventures, often originating from academic research, with the goal of developing ground-breaking treatments for severe diseases. Karolinska Development leverages its team's expertise in research, development, and commercialization to guide its portfolio companies, providing both capital and strategic support to advance innovations toward the market.

Recent filings

Filing Released Lang Actions
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update Classification · 1% confidence The document is a press release from Karolinska Development AB regarding the extension of a subscription period for a directed share issue (a capital raising activity). It details the reasons for the extension, the new timeline, and mentions the involvement of financial advisors. While it discusses capital structure, it is an announcement of an ongoing process rather than a formal financial report or a standalone regulatory filing. Given the specific nature of the announcement regarding share issuance and capital changes, it fits best under the 'Capital/Financing Update' category.
2019-09-12 Swedish
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update Classification · 1% confidence The document is a press release from Karolinska Development AB regarding the extension of a subscription period for a directed share issue (a capital raising activity). It details the reasons for the extension, the new timeline, and mentions the involvement of financial advisors. While it discusses capital structure, it is an announcement of an ongoing process rather than a formal financial report or a standalone regulatory filing. Given the specific nature of the announcement regarding share issuance and capital changes, it fits best under the 'Capital/Financing Update' category.
2019-09-12 Swedish
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update Classification · 1% confidence The document is a press release from Karolinska Development AB regarding the extension of a subscription period for a directed share issue (a capital raising activity). It details the reasons for the extension, the new timeline, and mentions the involvement of financial advisors. While it discusses capital structure, it is an announcement of an ongoing process rather than a formal financial report or a standalone regulatory filing. Given the specific nature of the announcement regarding share issuance and capital changes, it fits best under the 'Capital/Financing Update' category.
2019-09-12 Swedish
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the extension of a subscription period for a directed share issue. It details the reasons for the extension, the new timeline, and the involvement of financial and legal advisers. While it mentions an attachment, the text itself provides the substantive details of the capital change/financing activity. Therefore, it is classified as a Capital/Financing Update (CAP).
2019-09-12 English
Karolinska Development extends the subscription period in the directed share issue to holders of the Company’s convertible loan
Capital/Financing Update Classification · 1% confidence The document is a press release announcing the extension of a subscription period for a directed share issue. It details the reasons for the extension, the new timeline, and the involvement of financial and legal advisers. While it mentions an attachment, the text itself provides the substantive details of the capital change/financing activity. Therefore, it is classified as a Capital/Financing Update (CAP).
2019-09-12 English
Karolinska Development förlänger teckningsperioden i den riktade nyemissionen till Bolagets konvertibelinnehavare
Capital/Financing Update Classification · 1% confidence The document is a press release from Karolinska Development AB regarding the extension of a subscription period for a directed share issue (a capital raising activity). It details the reasons for the extension, the new timeline, and mentions the involvement of financial advisors. While it discusses capital structure, it is an announcement of an ongoing process rather than a formal financial report or a standalone regulatory filing. Given the specific nature of the announcement regarding share issuance and capital changes, it fits best under the 'Capital/Financing Update' category.
2019-09-12 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.